Chemical genomics in yeast
暂无分享,去创建一个
[1] Robert Lucito,et al. RNA interference microarrays: high-throughput loss-of-function genetics in mammalian cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[2] Ronald W. Davis,et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. , 1999, Science.
[3] J. Keller,et al. Chemopreventive Strategies Using NSAIDs and COX-2 Inhibitors , 2003, Cancer biology & therapy.
[4] Hirotada Mori,et al. From the sequence to cell modeling: comprehensive functional genomics in Escherichia coli. , 2004, Journal of biochemistry and molecular biology.
[5] E. Berger. The ribosomes of Drosophila , 2004, Molecular and General Genetics MGG.
[6] Ronald W. Davis,et al. Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar–coding strategy , 1996, Nature Genetics.
[7] Gary D Bader,et al. Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants , 2001, Science.
[8] Stuart L Schreiber,et al. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation , 2004, Nature Biotechnology.
[9] Rong Wang,et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity , 2001, Nature.
[10] Michel Roberge,et al. Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[11] Patrick J. Paddison,et al. A resource for large-scale RNA-interference-based screens in mammals , 2004, Nature.
[12] R. Aramayo,et al. Improving the efficiency of gene replacements in Neurospora crassa: a first step towards a large-scale functional genomics project. , 2002, Fungal genetics and biology : FG & B.
[13] S. D. de Kloet,et al. Effect of 5-fluorouracil on the synthesis and stability of ribosomal RNA in Saccharomyces carlsbergensis. , 1972, Archives of biochemistry and biophysics.
[14] Anders Olsen,et al. An automated high-throughput assay for survival of the nematode Caenorhabditis elegans. , 2003, Free Radical Biology & Medicine.
[15] James R. Knight,et al. A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae , 2000, Nature.
[16] Reuven Agami,et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway , 2004, Nature.
[17] Elizabeth A. Winzeler,et al. Genomic profiling of drug sensitivities via induced haploinsufficiency , 1999, Nature Genetics.
[18] A. Kalgutkar,et al. Discovery and design of selective cyclooxygenase-2 inhibitors as non-ulcerogenic, anti-inflammatory drugs with potential utility as anti-cancer agents. , 2001, Current drug targets.
[19] Stanley Fields,et al. Quantitative genome-wide analysis of yeast deletion strain sensitivities to oxidative and chemical stress , 2004 .
[20] H. Pitot,et al. Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine. , 1973, The Journal of biological chemistry.
[21] D. Santi,et al. 5-Fluoro-2'-deoxyuridylate: covalent complex with thymidylate synthetase. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. C. Hinshaw,et al. Discovering Modes of Action for Therapeutic Compounds Using a Genome-Wide Screen of Yeast Heterozygotes , 2004, Cell.
[23] K. Ghoshal,et al. An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug. , 1997, Biochemical pharmacology.
[24] Michael I. Jordan,et al. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. , 2004, Proceedings of the National Academy of Sciences of the United States of America.